Factors associated with human papillomavirus infection – findings from a cervical cancer screening program for female employees in Beijing

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F10451482
   PubMed Web of Science ®Google Scholar
• Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1–7. doi:10.1128/CMR.16.1.1-17.200312525422
   PubMed Web of Science ®Google Scholar
• Kour P, lal M, Panjaliya R, et al. Study of the risk factors associated with cervical cancer. Biomed Pharmacol J. 2010;3:1.
   Google Scholar
• Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114–2119. doi:10.1001/jama.287.16.211411966386
   PubMed Web of Science ®Google Scholar
• Wu J, Luo X, Wu X. Result analysis of 8463 cases of cervical cancer screening. Chin J Clin Gynecology Child Med. 2011;7(3):161–165.
   Google Scholar
• Xu H. Value of liquid-based ultrathin cell technology in the diagnosis of cervical lesions. Chin J Maternal and Child Health. 2010;25(34):5140–5141.
   Google Scholar
• Wang R, Guo XL, Wisman GB, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis. 2015;15(1):257. doi:10.1186/s12879-015-0998-526142044
   PubMed Web of Science ®Google Scholar
• Kliucinskas M, Nadisauskiene RJ, Minkauskiene M. Prevalence and risk factors of HPV infection among high-risk rural and urban Lithuanian women. Gynecol Obstet Invest. 2006;62(3):173–180. doi:10.1159/00009357216717474
   PubMed Web of Science ®Google Scholar
• Wei B, Li X, Qi J. Analysis of detection results of 13452 cases of HPV subtype infection. Marker Immunoassay Clin. 2013;20(3):169–171.
   Google Scholar
• Singh S, Zhou Q, Yu Y, et al. Distribution of HPV genotypes in Shanghai women. Int J Clin Exp Pathol. 2015;8(9):11901–11908.26617946
   PubMed Web of Science ®Google Scholar
• Wu S, Liao C, Huang Y, et al. Analysis of the detection results of human papillomavirus of reproductive tract in 6493 women in Guangzhou area. Chin J Pract Gynecology Obstetrics. 2011;6:453–456.
   Google Scholar
• Yang Y, Wang J, Sui X, et al. Analysis of the results of cervical cancer screening in Wuxi from 2013 to 2014. Zhonghua Yu Fang Yi Xue Za Zhi. 2016;50(5):451–454. doi:10.3760/cma.j.issn.0253-9624.2016.05.01227141903
   PubMedGoogle Scholar
• Wang YY, Lin W, Wu B, et al. Distribution and associated factors of high-risk HPV genotypes infection among HPV-positive women who participated cervical screening test in Shenzhen, 2014–2016, China. Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52(5):480–485. doi:10.3760/cma.j.issn.0253-9624.2018.05.00629747339
   PubMedGoogle Scholar
• Chen Z, Wang Q, Ding X, et al. Characteristics of HPV prevalence in Sichuan Province, China. Int J Gynaecol Obstet. 2015;131(3):277–280. doi:10.1016/j.ijgo.2015.06.02726391672
   PubMed Web of Science ®Google Scholar
• Sun ZR, Ji YH, Zhou WQ, et al. Characteristics of HPV prevalence among women in Liaoning province, China. Int J Gynaecol Obstet. 2010;109(2):105–109. doi:10.1016/j.ijgo.2009.11.02620138618
   PubMed Web of Science ®Google Scholar
• De Sanjosé S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453–459. doi:10.1016/S1473-3099(07)70158-517597569
   PubMed Web of Science ®Google Scholar
• Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. 2005;337(1):76–84. doi:10.1016/j.virol.2005.04.00215914222
   PubMed Web of Science ®Google Scholar
• Trimble CL, Piantadosi S, Gravitt P, et al. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clin Cancer Res. 2005;11(13):4717–4723. doi:10.1158/1078-0432.CCR-04-259916000566
   PubMed Web of Science ®Google Scholar
• Andersson S, Safari H, Mints M, et al. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br J Cancer. 2005;92(12):2195–2200. doi:10.1038/sj.bjc.660264815942630
   PubMed Web of Science ®Google Scholar
• Zhao J, Guo Z, Wang Q, et al. Human papillomavirus genotypes associated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China. Infect Agent Cancer. 2017;12:8. doi:10.1186/s13027-017-0116-y28138337
   PubMed Web of Science ®Google Scholar
• Lowndes CM. Vaccines for cervical cancer. Epidemiol Infect. 2006;134(1):1–12. doi:10.1017/S095026880500572816409645
   PubMed Web of Science ®Google Scholar
• Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372(8):711–723. doi:10.1056/NEJMoa140504425693011
   PubMed Web of Science ®Google Scholar
• Cotton SC, Sharp L, Seth R, et al. Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. Br J Cancer. 2007;97(1):133–139. doi:10.1038/sj.bjc.660382217519896
   PubMed Web of Science ®Google Scholar
• Kahn JA, Lan D, Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol. 2007;110(1):87–95. doi:10.1097/01.AOG.0000266984.23445.9c17601901
   PubMed Web of Science ®Google Scholar
• Ye J. Epidemiological investigation of HPV in Zhejiang and the role of cervical cancer risk factors in HPV screening [dissertation]. Zhejiang University; 2010.
   Google Scholar
• Wellings K, Collumbien M, Slaymaker E, et al. Sexual behaviour in context: a global perspective. Lancet. 2006;368(9548):1706–1728. doi:10.1016/S0140-6736(06)69479-817098090
   PubMed Web of Science ®Google Scholar
• Zheng Z, Zhou Y, Zheng L, et al. Sexual behaviour and contraceptive use among unmarried, young women migrant workers in five cities in China. Reprod Health Matters. 2001;9(17):118–127. doi:10.1016/S0968-8080(01)90015-111468827
   PubMed Web of Science ®Google Scholar
• Sherman SM, Bartholomew K, Denison HJ, et al. Knowledge, attitudes and awareness of the human papillomavirus among health professionals in New Zealand. PLoS One. 2018;13(12):e0197648. doi:10.1371/journal.pone.019764830596646
   PubMed Web of Science ®Google Scholar
• Chawla PC, Chawla A, Chaudhary S. Knowledge, attitude & practice on human papillomavirus vaccination: a cross-sectional study among healthcare providers. Indian J Med Res. 2016;144(5):741–749. doi:10.4103/ijmr.IJMR_1106_1428361828
   PubMedGoogle Scholar
• Zahedi L, Sizemore E, Malcolm S, et al. Knowledge, attitudes and practices regarding cervical cancer and screening among haitian health care workers. Int J Environ Res Public Health. 2014;11(11):11541–11552. doi:10.3390/ijerph11111154125390794
   PubMed Web of Science ®Google Scholar
• Maharajan MK, Rajiah K, Num KS, et al. Knowledge of human papillomavirus infection, cervical cancer and willingness to pay for cervical cancer vaccination among ethnically diverse medical students in Malaysia. Asian Pac J Cancer Prev. 2015;16(14):5733–5739. doi:10.7314/APJCP.2015.16.14.573326320444
   PubMedGoogle Scholar
• Pelullo CP, Esposito MR, Di Giuseppe G. Human papillomavirus infection and vaccination: knowledge and attitudes among nursing students in Italy. Int J Environ Res Public Health. 2019;16:10. doi:10.3390/ijerph16101770
   Web of Science ®Google Scholar
• Wu RF, Dai M, Qiao YL, et al. Human papillomavirus infection in women in Shenzhen City, People’s Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer. 2007;121(6):1306–1311. doi:10.1002/ijc.2272617417776
   PubMed Web of Science ®Google Scholar
• Chen Z, Meng W, DU R, et al. Genotype distribution and the relative risk factors for human papillomavirus in Urumqi, China. Exp Ther Med. 2013;6(1):85–90. doi:10.3892/etm.2013.107323935724
   PubMed Web of Science ®Google Scholar
• Tang HR, Zhou YQ, Wu LN, et al. Human papillomavirus infection and cervical intraepithelial neoplasia morbidity of women from different occupations in Shenzhen city, China. Zhonghua Liu Xing Bing Xue Za Zhi. 2007;28(10):951–953.18399137
   PubMedGoogle Scholar
• Lakew Y, Tamene H. HIV related risk behaviours among taxi drivers and their assistants in Addis Ababa, Ethiopia: descriptive cross-sectional survey. BMC Public Health. 2014;14(1):330. doi:10.1186/1471-2458-14-33024712295
   PubMedGoogle Scholar
• Nakasone Y, Nadoyama T. Present state of respiratory tract infection prevention for taxi drivers. Jan J Infect Prev Control. 2011;26(3):167–171. doi:10.4058/jsei.26.167
   Google Scholar
• Landy R, Birke H, Castanon A, et al. Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years. Br J Cancer. 2014;110(7):1841–1846. doi:10.1038/bjc.2014.6524518600
   PubMed Web of Science ®Google Scholar